Literature DB >> 2412787

Infant VEP acuity measurements: analysis of individual differences and measurement error.

A M Norcia, C W Tyler.   

Abstract

The reliability of visual evoked potential (VEP) measurements of acuity was determined by estimating acuity for sinewave luminance gratings which were counterphase modulated at either 12 or 20 reversals/sec (rps). Gratings were swept in spatial frequency beyond the acuity limit and acuity was estimated from an extrapolation based on the last peak in the VEP amplitude versus spatial frequency function. Twenty-five infants ranging in age from 17 to 25 weeks were studied. Individual 10 sec sweeps resulted in records with a criterion response in 65-75% of trials. The reliability of acuities obtained from individual 10 sec sweeps was +/- 0.54 octaves at 95% confidence across 12 and 20 rps recording conditions (RMS error of +/- 0.27 octaves). The best acuity attained by each infant on either a single sweep, or on their vector average, was reliable to +/- 0.38 octaves at 95% confidence (RMS error of +/- 0.19 octaves) compared to a range of individual acuities of about 2 octaves. Much of the variability of sweep VEP acuity in cross-sectional samples of infants is therefore attributable to reliable individual differences rather than to measurement error. In testing individual infants our analysis indicates that choice of temporal frequency accounts for only 14% of the variation in acuity estimates within subjects.

Entities:  

Mesh:

Year:  1985        PMID: 2412787     DOI: 10.1016/0013-4694(85)91026-0

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  26 in total

1.  The dependency of simultaneously recorded retinal and cortical potentials on temporal frequency.

Authors:  Monika Heine; Thomas Meigen
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

2.  Reliability of acuities determined with the sweep visual evoked potential (sVEP).

Authors:  William H Ridder; Anna Tong; Theresa Floresca
Journal:  Doc Ophthalmol       Date:  2012-01-20       Impact factor: 2.379

Review 3.  Nystagmus in infancy.

Authors:  I Casteels; C M Harris; F Shawkat; D Taylor
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

4.  Objective measurement of human visual acuity by visual evoked potentials.

Authors:  A K Kharauzov; S V Pronin; A F Sobolev; S A Koskin; E V Boiko; Yu E Shelepin
Journal:  Neurosci Behav Physiol       Date:  2006-11

5.  A new method of extrapolating the sweep pattern visual evoked potential acuity.

Authors:  Peng Zhou; Ming-Wei Zhao; Xiao-Xin Li; Xiao-Feng Hu; Xi Wu; Lan-Jun Niu; Wen-Zhen Yu; Xiu-Lan Xu
Journal:  Doc Ophthalmol       Date:  2007-10-31       Impact factor: 2.379

6.  Monocular and binocular steady-state flicker VEPs: frequency-response functions to sinusoidal and square-wave luminance modulation.

Authors:  David S Nicol; Ruth Hamilton; Uma Shahani; Daphne L McCulloch
Journal:  Doc Ophthalmol       Date:  2011-01-29       Impact factor: 2.379

7.  A comparison of contrast sensitivity and sweep visual evoked potential (sVEP) acuity estimates in normal humans.

Authors:  William H Ridder
Journal:  Doc Ophthalmol       Date:  2019-08-14       Impact factor: 2.379

8.  A frequency-tagging electrophysiological method to identify central and peripheral visual field deficits.

Authors:  Noémie Hébert-Lalonde; Lionel Carmant; Dima Safi; Marie-Sylvie Roy; Maryse Lassonde; Dave Saint-Amour
Journal:  Doc Ophthalmol       Date:  2014-05-10       Impact factor: 2.379

9.  Early visual-evoked potential acuity and future behavioral acuity in cortical visual impairment.

Authors:  Tonya Watson; Deborah Orel-Bixler; Gunilla Haegerstrom-Portnoy
Journal:  Optom Vis Sci       Date:  2010-02       Impact factor: 1.973

10.  Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.

Authors:  Sivan Durbin; Giuseppe Mirabella; J Raymond Buncic; Carol A Westall
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.